Glaxosmithkline Biologicals Sa v Comptroller-General Of Patents, Designs And Trade Marks: ECJ 14 Nov 2013

ECJ Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Concepts of ‘active ingredient’ and ‘combination of active ingredients’ – Adjuvant
References: C-210/13, [2013] EUECJ C-210/13
Links: Bailii
Judges: Caoimh P
Statutes: Regulation (EC) No 469/2009

Last Update: 23 September 2020; Ref: scu.518459